Unknown

Dataset Information

0

Activity-Based Protein Profiling Reveals That Cephalosporins Selectively Active on Non-replicating Mycobacterium tuberculosis Bind Multiple Protein Families and Spare Peptidoglycan Transpeptidases.


ABSTRACT: As ?-lactams are reconsidered for the treatment of tuberculosis (TB), their targets are assumed to be peptidoglycan transpeptidases, as verified by adduct formation and kinetic inhibition of Mycobacterium tuberculosis (Mtb) transpeptidases by carbapenems active against replicating Mtb. Here, we investigated the targets of recently described cephalosporins that are selectively active against non-replicating (NR) Mtb. NR-active cephalosporins failed to inhibit recombinant Mtb transpeptidases. Accordingly, we used alkyne analogs of NR-active cephalosporins to pull down potential targets through unbiased activity-based protein profiling and identified over 30 protein binders. None was a transpeptidase. Several of the target candidates are plausibly related to Mtb's survival in an NR state. However, biochemical tests and studies of loss of function mutants did not identify a unique target that accounts for the bactericidal activity of these beta-lactams against NR Mtb. Instead, NR-active cephalosporins appear to kill Mtb by collective action on multiple targets. These results highlight the ability of these ?-lactams to target diverse classes of proteins.

SUBMITTER: Lopez Quezada L 

PROVIDER: S-EPMC7324553 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Activity-Based Protein Profiling Reveals That Cephalosporins Selectively Active on Non-replicating <i>Mycobacterium tuberculosis</i> Bind Multiple Protein Families and Spare Peptidoglycan Transpeptidases.

Lopez Quezada Landys L   Smith Robert R   Lupoli Tania J TJ   Edoo Zainab Z   Li Xiaojun X   Gold Ben B   Roberts Julia J   Ling Yan Y   Park Sae Woong SW   Nguyen Quyen Q   Schoenen Frank J FJ   Li Kelin K   Hugonnet Jean-Emmanuel JE   Arthur Michel M   Sacchettini James C JC   Nathan Carl C   Aubé Jeffrey J  

Frontiers in microbiology 20200623


As β-lactams are reconsidered for the treatment of tuberculosis (TB), their targets are assumed to be peptidoglycan transpeptidases, as verified by adduct formation and kinetic inhibition of <i>Mycobacterium tuberculosis</i> (Mtb) transpeptidases by carbapenems active against replicating Mtb. Here, we investigated the targets of recently described cephalosporins that are selectively active against non-replicating (NR) Mtb. NR-active cephalosporins failed to inhibit recombinant Mtb transpeptidase  ...[more]

Similar Datasets

| S-EPMC4947980 | biostudies-literature
| S-EPMC5610527 | biostudies-literature
| S-EPMC7241432 | biostudies-literature
| S-EPMC4941221 | biostudies-literature
| S-EPMC6196517 | biostudies-literature
2024-07-30 | GSE270128 | GEO
| S-EPMC3591469 | biostudies-literature
| S-EPMC8126863 | biostudies-literature
| S-EPMC3127080 | biostudies-other
| S-EPMC3993333 | biostudies-literature